Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
In this edition of Pathways Picks: FDA provides more details on the draft MDUFA VI agreement, including user fee distinctions between US and foreign companies; Dem lawmaker seeks scrutiny; FDA and CMS hiring; Medicare floats remote monitoring restrictions; Australia updates its advertising rules; Brazil and Chile regulators meet; and more global medtech policy updates.
Watchful waiting has hitherto been the best course for smaller abdominal aortic aneurysms, although they are likely to grow, and could unexpectedly rupture. There is hope on the horizon; Nectero recently published two-year FIH data, and Angiolutions emerges with what its founders call a first-in-class mechanobiological device strategy.
Health ministers push for changes and action on MDR/IVDR reforms. Excerpted from Pathways’ Picks June 17: EU Health Ministers Weigh Reforms, UK-US Liaisons, and TAVR Milestone.